Curiosity is a Strategy — Biolinq’s Rebecca Gottlieb

Innovation doesn’t happen by accident. It happens when leaders intentionally design the systems that allow curiosity, experimentation, and good ideas to survive. In this episode of the Women in MedTech podcast, host Kayleen Brown sits down with Dr. Rebecca Gottlieb, VP of Advanced Sensor Technologies at Biolinq, to explore what it really takes to build innovation engines inside regulated MedTech environments. From early clinical work with artificial heart patients, to more than two decades of sensor innovation at Medtronic, to leading advanced biosensing platforms at Biolinq, Rebecca explains why curiosity isn’t just a mindset — it’s a leadership strategy. Kayleen also welcomes Chris Dawson, Head of Biosensing at TTP PLC, to unpack what curiosity looks like in practice: how multidisciplinary teams explore what’s possible, retire risk early, and build systems that support innovation without compromising reliability or regulatory rigor. Thank you to TTP for your support, to learn more visit: https://www.ttp.com. Before you go, make sure to download your complimentary e-books from TTP today!  Rethinking Regulatory Compliance -  How to turn regulatory demands in MedTech into development strengths Optimising Bluetooth Connectivity in Implantable Medical Devices Automated Biosensor Testing for the Development of Continuous Health Monitors *** Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players:https://women-in-medtech.castos.com/subscribe Follow us on YouTube:https://www.youtube.com/@DeviceTalks Want access to the complete DeviceTalks Podcast Network (DTPN)?Follow us at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Why innovation systems matter in MedTech(00:00:01) - Introducing in-studio guest, Chris Dawson, TTP(00:00:02) - What innovation looks like inside multidisciplinary teams(00:00:03) - Start of keynote interview with Rebecca Gottlieb, Biolinq(00:00:04) - From startup to Medtronic: scaling innovation across environments(00:00:05) - Internal venture programs: designing systems for ideas to surface(00:00:06) - Leadership as barrier removal, not control(00:00:07) - Why Rebecca chose Biolinq: platforms, microneedles, and possibility(00:00:08) - Rethinking glucose monitoring for Type 2 diabetes(00:00:09) - FDA De Novo clearance and sustaining teams through long timelines(00:00:10) - The future of biosensing: DNA-based receptors and new analytes(00:00:11) - Leadership reflections and closing: curiosity as an innovation engine